When it comes to diabetes technologies, and especially AID systems, the themes of increased food freedom and relaxed mealtime bolus dosing practices were prevalent in our study, often resulting in increased consumption of higher glycemic index foods, larger portion sizes, inconsistent pre-bolus dosing, and imprecise carbohydrate/insulin matching. This evidence concerns the gene INS and diabetes mellitus.